Melanotan 1 and Melanotan 2 are among the most researched melanocortin peptides in scientific literature. While both are synthetic analogues of alpha-melanocyte stimulating hormone (α-MSH), they differ significantly in their molecular structure, receptor selectivity, and research applications. This overview explores what the scientific literature tells us about each compound and where the key differences lie.
All information is presented strictly for educational and research purposes only.
Origins — Where Did These Compounds Come From?
Both Melanotan 1 and Melanotan 2 were originally developed to investigate their effects on melanin production with the aim of increasing the natural photoprotective effect provided by the hormone α-MSH. Both molecules proved effective at increasing melanin when studied, and the type of melanin produced was eumelanin — which provides greater protection to cells than pheomelanin. ChemicalBook
However, the two compounds diverged significantly in their research trajectories due to differences in their receptor profiles and resulting side effect signatures.
Molecular Structure — Linear vs Cyclic
Melanotan 1 is a 13 amino acid linear peptide in which the fourth amino acid, methionine, is replaced with norleucine and the seventh amino acid, L-phenylalanine, is replaced with D-phenylalanine. This molecule is more resistant to breakdown than its natural analogue, meaning the stimulus received by its receptor — principally MC1R — is more potent. Melanotan 2 is a shorter variant with a lactam ring, making it more potent than natural α-MSH but with more side effects because it is less receptor-specific. ChemicalBook
This structural difference — linear versus cyclic — is fundamental to understanding why the two compounds produce such different research profiles.
Receptor Selectivity — The Core Difference
Melanotan 1 shows strong activity at MC1R while Melanotan 2 acts on many receptors. This difference helps explain why Melanotan 1 mainly affects pigmentation while Melanotan 2 has broader effects. Peptide-works
Melanotan 2 demonstrates broader melanocortin receptor pharmacology with significant binding affinity across MC1R, MC3R, MC4R, and MC5R subtypes. In vitro binding studies reveal EC50 values of 0.3 nM at MC1R, 2.1 nM at MC3R, 1.1 nM at MC4R, and 2.8 nM at MC5R in respective transfected cell models. This pan-melanocortin activity distinguishes Melanotan 2 from the MC1R-selective profile of Melanotan 1. Elementsarms
Research Applications
Due to their differing receptor profiles, the two compounds have been studied in distinctly different research contexts.
Melanotan 1 research has primarily focused on pigmentation biology, photoprotection, and photosensitivity disorders. Melanotan 1 is being studied in Phase 2 and Phase 3 clinical trials as a photoprotective compound for protection against nonmelanoma skin cancer and in photoinduced skin diseases such as erythropoietic protoporphyria, solar dermatitis, and polymorphic light eruption. ChemicalBook
Melanotan 2 research has explored a broader range of areas. Melanotan 2 with its broader receptor activity shows additional effects in studies of appetite regulation, energy balance, and sexual stimulation. Research demonstrates that Melanotan 2 engages multiple melanocortin receptors and models show appetite suppression and reduced food intake. Direct Peptides
Side Effect Profiles — A Significant Distinction
The two compounds differ markedly in their reported side effect profiles, which is a key consideration for researchers selecting between them.
Melanotan 1 is mostly linked with skin darkening as an expected effect and mild reactions like temporary flushing, as it mainly acts on MC1R. Melanotan 2 interacts with more receptors and may cause broader effects such as nausea, reduced appetite, and changes in sexual function. Some studies also report headaches, fatigue, and flushing. Peptide-works
Because Melanotan 2 can cross the blood-brain barrier and is nonselective, it also activates other melanocortin receptors, resulting in adverse events including fatigue, loss of appetite, and penile erection. PubMed Central
Half-Life and Duration
Melanotan 1 has a longer half-life compared to Melanotan 2, which means it remains active for a longer duration. Melanotan 2, on the other hand, is known to offer more rapid and pronounced results due to its shorter half-life. Suretan
Melanotan 1 demonstrates superior stability in serum-containing media with half-life values exceeding 4 hours under standard cell culture conditions, while Melanotan 2 shows moderate proteolytic resistance with detectable degradation occurring after 2 to 3 hours in serum-containing assay buffers. Elementsarms
Regulatory Status
Melanotan 1 has FDA approval for erythropoietic protoporphyria as a prescription implant and has undergone formal clinical trials. Melanotan 2 was never submitted for FDA approval as a drug and remains a research chemical in the US and most other jurisdictions. PeptideDeck
Selecting the Right Compound for Research
For researchers, the practical takeaway is that Melanotan 1 versus Melanotan 2 selection should be driven by the primary endpoint — pigmentation-centric readouts versus CNS-linked melanocortin readouts, plus the design constraints of the model being used. If the primary endpoint is pigmentation biology, Melanotan 1 analogues are more commonly discussed in that context. If the primary endpoint is CNS-linked melanocortin signalling, Melanotan 2 is more commonly selected in preclinical paradigms exploring those circuits. PeptideSciences
Research Grade Supply from BioSupply UK
BioSupply UK supplies both Melanotan 1 and Melanotan 2 as research grade compounds at 99%+ purity, independently third party lab tested and HPLC verified. Both are available in 10mg vials with Certificates of Analysis available on request. Strictly for laboratory and in-vitro scientific research only.
This content is provided for educational and research purposes only and does not constitute medical advice. Neither compound is approved for human cosmetic or therapeutic use outside of licensed clinical settings.